4
Changes in Ownership
Arcadia Biosciences, Inc. Filed Acc 0001209191-19-049077
Chief Executive Officer bought 2,000 shares at an average $6.51 ($13,014)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Plavan Matthew T Chief Executive Officer | 2019-09-10 | Purchase | +1,000 | $6.49 | $6,493 | 9,000 | D |
| Plavan Matthew T Chief Executive Officer | 2019-09-10 | Purchase | +1,000 | $6.52 | $6,521 | 10,000 | D |
| Open-market purchases · 2,000 sh · avg $6.51 · $13,014 | |||||||
Loading xslF345X03/doc4.xml…